Severe combined immunodeficiency
ORPHA:183660Clinical groupAutosomal recessive, X-linked recessiveInfancy, Neonatal
Эпидемиология9
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-9 / 100 000 | 1.65 | Europe | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 1.6 | France | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 1.7 | Greece | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 1.75 | Australia | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 1.28 | Chile | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 3.79 | Costa rica | Value and class |
| Point prevalence | Unknown | — | Worldwide | Class only |
| Prevalence at birth | 1-9 / 100 000 | 1.72 | United States | Value and class |
| Prevalence at birth | 1-9 / 100 000 | — | Worldwide | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)